AngioDynamics Vortex Port Lawsuit Filed Over Infection, Need for Surgical Removal
Manufacturers failed to warn the public of high failure rates linked to AngioDynamics port catheters, lawsuit claims.
Manufacturers failed to warn the public of high failure rates linked to AngioDynamics port catheters, lawsuit claims.
The direct filing process is expected to speed up the process for filing new port catheter lawsuits, and coordinate allegations raised in a rapidly growing number of claims being brought against AngioDynamics.
Lawsuit accuses AngioDynamics of failing to warn the public and doctors about known risk of infection and failure of the Xcela port catheter.
Catheters with special coatings fared no better than polyurethane when it came to infection and thrombosis risks.
A piece of the fractured AngioDynamics Vaxcel port migrated into a woman's heart and was unable to be removed.
Judge is reviewing a motion to appoint a group of 12 lawyers involved in AngioDynamics port catheter lawsuits to serve in various leadership positions, which will be discussed at a status conference on December 19.
Minnesota woman had to have an AngioDynamics port catheter surgically removed after doctors determined it was the source of a staph infection.
Materials used in the port catheter cause patients to face an increased risk of infections, according to recently filed AngioDymanics Xcela lawsuit.
Presiding Judge Ohta is expected to appoint a group of AngioDynamics port catheter lawyers to leadership positions, and prepare a group of bellwether cases for early test trials over the next few years.
Broken pieces of the Angiodynamics Vortex chemo port have been deemed too dangerous to remove from the plaintiff’s veins.